Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region
26 mars 2024 08h21 HE
|
AcedrA BioPharmaceuticals
AcedrA will commercialize 36 essential medicines in the 12 countries within the Middle East and North Africa region
TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
18 mars 2024 12h19 HE
|
AcedrA BioPharmaceuticals; TaiMed Biologics
TaiMed and AcedrA officially signed an exclusive license, commercialization, and distribution agreement for Trogarzo in the MENA region.